One example of a statistical model for HCC risk assessment in patients with chronic liver disease is GALAD, a serum biomarker-based model that incorporates sex, age, AFP, lectin-bound AFP (AFP-L3), and DCP (52,53). The gene discussed is AFP; the disease is hepatocellular carcinoma.